Percent reduction of B-cells antigens following overnight treatment of PBMCs.
收藏NIAID Data Ecosystem2026-03-08 收录
数据链接：
官方服务：
资源简介：
Average % reduction from three experiments using PBMCs form independent donors. n.d., not measured due to blocked detection by the specific treatment. Significantly (P<0.05) more reduction than: aall other agents; bveltuzumab and hA19; cepratuzumab; dall but veltuzumab. eNot significantly different from 22*-(20)-(20).
创建时间：
2014-05-19
